[Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
In the light of a survey of the pertinent literature the results of tissue plasminogen activator and pro-urokinase++ use in the thrombolytic treatment of acute myocardial infarction are discussed.